NCT02365701View on ClinicalTrials.gov

Study of Motilitone to Treat Functional Dyspepsia

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Dyspepsia
Interventions
DRUG

Motilitone 30mg

30mg of Motilitone in tablet form, to be taken 3 times daily for 4 weeks

DRUG

Placebo

Placebo, in tablet form, to be taken 3 times daily for 4 weeks. The placebo is the same formulation as Motilitone except that it does not contain the active pharmaceutical ingredient.

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02365701 - Study of Motilitone to Treat Functional Dyspepsia | Biotech Hunter | Biotech Hunter